Urinary Tract Infections - Current Issues in Pathogenesis and Treatment;Infekcije Mokraćnog Sustava - Novosti u Patogenezi i Liječenje

Medicus

Volumn 12, Issue 2, 2003, Pages 197-204

  Škerk, Višnja ^a  

^a Ministarstva Zdravstva i Socijalne Skrbi RH   (Croatia)

Author keywords

Antimicrobic medications; Microbiology; Treatment; Urinary tract infections

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; KLAVOCIN; NITROFURANTOIN; NORFLOXACIN; OXIDIZED CELLULOSE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ASYMPTOMATIC BACTERIURIA; CHEMOPROPHYLAXIS; CLINICAL FEATURE; CONTROLLED STUDY; CYSTITIS; EMPIRICISM; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; LEUKOCITURIA; NEWBORN; PATHOGENESIS; POSTOPERATIVE COMPLICATION; PREGNANCY COMPLICATION; PRESCHOOL CHILD; PYELONEPHRITIS; RECURRENT INFECTION; REVIEW; RISK FACTOR; TREATMENT OUTCOME; URINALYSIS; URINARY DYSFUNCTION; URINARY TRACT INFECTION; URINARY TRACT MALFORMATION;

EID: 1942438079     PISSN: 1330013X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. COHEN J, POWDERLY WG. Infectious Diseases. London: Mosby, 2003.
2. SOBEL JD, KAYE D. Urinary tract infections. In: Mandell GL, Bennett JE, Dolni RE (eds.) Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone, 2000:733-805.
3. EMÖDY L, KERENYI M, NAGY G. Virulence factors of uropathogenic Escherichia coli. Int J Antimicrob Agents 2003;22:S29-S33.
4. ŠKERK. V, KRHEN I, SCHÖNWALD S, MAREKOVIĆ Z. Antimikrobno lijećenje infekcija mokradnog sustava. Liječ Vjesn. 2001;123:16-25.
5. SKERK V. Infekcije urinarnog trakta. Medicus 1999;8:207-13.
6. RAZ R. Asymptomatic bacteriuria. Clinical significance and management. Int J Antimicrob Agents 2003;22: S45-S47.
7. HOOTON TM. Recurrent urinary tract infection in women. Int J Antimicrob Agents 2001;17:259-68.
8. NABER KG. Experience with the new guidelines on evaluation of new antiinfective drugs for the treatment of urinary tract infections. Int J Antimicrob Agents 1999;11:189-96.
9. KALENIĆ S, TAMBIĆ T, TAMBIČ A, FRANCETIĆ I. Rezistencija bakterija na antibiotike u Hrvatskoj godine 1998. i 1999. Liječ Vjesn 2000;122:198-9.
10. Osjetljivost i rezistencija bakterija na antibiotike u Republici Hrvatskoj u 2002. godini. Zagreb: Akademija medicinskih znanosti Hrvatske. 2003.